Gatifloxacin therapy for children: turn on the light Academic Article uri icon

abstract

  • We appreciate Dr. Marchant's commentary discussing gatifloxacin therapy for children [1], because it attempts to address some unsettling questions regarding the development of gatifloxacin oral suspension to treat children with recurrent acute otitis media or for whom acute otitis media treatment has failed. Two of us (RE and KH) led the gatifloxacin oral suspension clinical development team within Bristol-Myers Squibb, and 2 others (MP and RD) worked closely with Bristol-Myers Squibb throughout the 6-month preparations for …

publication date

  • January 1, 2005